Greetings!
There is what GMP says on paper. And then there is what happens when an inspector starts asking questions.
Terry Pilkey knows both sides of that conversation.
Across 44 years in the pharmaceutical industry, Terry has worked in government, regulatory affairs, quality control, consulting, and auditing. During her time with the Health Products and Food Branch Inspectorate of Health Canada, she performed GMP and Medical Device inspections, giving her firsthand experience with what inspectors look for and where compliance issues tend to surface.
She later took that experience into industry, most recently as Regulatory Affairs Director at Eurofins Biopharma Product Testing Toronto. Today, she is Quality & Compliance Department Head and an executive member at AAPS Pharma.
On September 24, Terry will lead GMP in Practice: What Inspections Expect for 2026, a practical workshop built around the realities of maintaining GMP compliance.
We’ll get into the things that matter when GMP moves from a requirement to everyday practice:
- Building stronger quality control and quality assurance practices
- Writing effective SOPs and maintaining reliable GMP documentation
- Investigating deviations and out-of-specification results
- Managing production controls, validation, and change control
- Building effective training and sanitation programs
- Getting your people, documentation, and systems ready for inspectors and auditors
The idea is not simply to revisit GMP principles. It is to understand what good compliance actually looks like in practice, where things can go wrong, and what an experienced inspector or auditor is likely to notice.
Choose how you'd like to attend: |
